COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | p21 / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | p21 | | 597.7 | 9 | 0049-0613 | 300.09 | 612.81 | 325 | 66.43 | 0.926 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | p21 / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | p21 | | 191.8 | 9 | 0050-0664 | 878.63 | 665.31 | 280 | 63.60 | 0.870 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 860.0 | 1 | 0001-0030 | 113.89 | 29.84 | 299 | 67.60 | 0.822 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1016.0 | 1 | 0002-0029 | 168.91 | 28.72 | 294 | 66.18 | 0.843 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4844.9 | 1 | 0003-0033 | 263.30 | 34.12 | 210 | 55.36 | 0.861 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 943.3 | 1 | 0004-0039 | 463.46 | 39.70 | 310 | 65.36 | 0.912 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 845.7 | 1 | 0005-0040 | 504.82 | 41.10 | 293 | 68.67 | 0.781 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 629.8 | 1 | 0006-0040 | 720.01 | 40.44 | 289 | 75.74 | 0.633 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 5499.9 | 1 | 0007-0041 | 803.55 | 41.85 | 444 | 87.50 | 0.729 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1974.6 | 1 | 0008-0042 | 418.82 | 41.04 | 267 | 61.11 | 0.898 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 9060.0 | 1 | 0009-0042 | 87.75 | 42.02 | 158 | 48.63 | 0.840 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1894.1 | 1 | 0010-0045 | 289.33 | 45.56 | 376 | 71.94 | 0.913 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3595.0 | 1 | 0011-0044 | 589.42 | 44.68 | 234 | 56.28 | 0.928 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2224.2 | 1 | 0012-0045 | 693.34 | 45.35 | 223 | 54.87 | 0.931 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3540.5 | 1 | 0013-0042 | 652.67 | 42.21 | 177 | 52.63 | 0.803 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1268.2 | 1 | 0014-0047 | 771.72 | 47.09 | 254 | 59.36 | 0.906 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2072.6 | 1 | 0015-0051 | 172.16 | 51.15 | 276 | 61.94 | 0.904 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 995.0 | 1 | 0016-0050 | 534.61 | 50.03 | 323 | 66.77 | 0.910 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1340.8 | 1 | 0017-0053 | 219.63 | 53.47 | 374 | 71.60 | 0.917 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1896.9 | 1 | 0018-0052 | 134.85 | 52.43 | 234 | 56.53 | 0.920 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3738.9 | 1 | 0019-0058 | 657.13 | 57.83 | 342 | 70.77 | 0.858 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1480.4 | 1 | 0020-0061 | 258.75 | 61.24 | 390 | 73.60 | 0.905 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1183.2 | 1 | 0021-0063 | 335.34 | 62.34 | 338 | 68.43 | 0.907 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2568.1 | 1 | 0022-0062 | 630.45 | 62.65 | 266 | 64.28 | 0.809 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2808.2 | 1 | 0023-0061 | 68.12 | 60.80 | 231 | 55.11 | 0.956 |